Janiesaysyay(@janiesaysyay) 's Twitter Profile Photo

and guides them in creating formulas for new variants, formulas for cancer and other diseases they want to use mRNA gene therapies on. They NEED this data.

twitter.com/SpookyJay36/st…

account_circle
Roberto Ferrara(@RobertoFerrara_) 's Twitter Profile Photo

Neutrophils are an heterogeneous immune population related to squamous hystology and able to drive immunesuppression and progression to ICI in NSCLC

Neutrophils are an heterogeneous immune population related to squamous hystology and able to drive immunesuppression and progression to ICI in NSCLC #AACR19 #OncoAlert
account_circle
Ashima Makol MD(@AshimaMakol) 's Twitter Profile Photo

✨ Phenomenal review of ’s by Dr. Seyahi

For Venous/Arterial Thrombosis
🎯 Immunesuppression is KEY! 👉 Anti-TNF 1st
🎯 Anticoag controversial but added if
👉 Low bleeding risk
👉 NO Pulmonary Artery aneurysm
👉 DOACs may be reasonable

✨ Phenomenal review of #Behcet’s by Dr. Seyahi #IRACON21 

For Venous/Arterial Thrombosis
🎯 Immunesuppression is KEY! 👉 Anti-TNF 1st
🎯 Anticoag controversial but added if 
      👉 Low bleeding risk
      👉 NO Pulmonary Artery aneurysm 
      👉 DOACs may be reasonable
account_circle
Nico Gagelmann(@NicoGagelmann) 's Twitter Profile Photo

After primary infection with B, it probably persists lifelong in hepatocyte nuclei & reactivates after immunesuppression eg hematopoietic cell transplant, risking fulminant hepatic failure.

Treatment:
entecavir or lamivudine
tenofovir (we saw graft failures)

After primary infection with #hepatitis B, it probably persists lifelong in hepatocyte nuclei & reactivates after immunesuppression eg hematopoietic cell transplant, risking fulminant hepatic failure. 

Treatment:
entecavir or lamivudine
tenofovir (we saw graft failures)
#bmtsm
account_circle
EANO(@EANOassociation) 's Twitter Profile Photo

Join our next webinar on advances in the immunotherapy for gliomas. Register now to attend the live event on Wednesday, July 28, 2021 16 -17:30 (CEST)👉bit.ly/3hkc51R👈
Peter Fecci Michael Platten 🇪🇺 OncoAlert

Join our next #eEANO webinar on advances in the immunotherapy for gliomas. Register now to attend the live event on Wednesday, July 28, 2021 16 -17:30 (CEST)👉bit.ly/3hkc51R👈 #glioblastoma
#immunesuppression #glioma #immunotherapy @PeterFecci @platten_michael @OncoAlert
account_circle
Dra. Teraiza Mesa R Cuenta Oficial ®(@Dra_TeraizaMesa) 's Twitter Profile Photo

RT Atanas G. Atanasov: IL-10-producing Tfh cells accumulate with age and link inflammation with age-related immune suppression


Other social media channels: inpst.net/social-media-c…
advances.sciencemag.org/cgi/content/sh…

account_circle